Citations 27

Fully Automated Deep Learning Model to Detect Clinically Significant Prostate Cancer at MRI

Radiology | August 6, 2024 | Volume: 312 | Issue: 2 | Pages: No page available

10.1148/radiol.232635 | PMID 39105640

The performance of a deep learning model was not different from that of radiologists in the detection of clinically significant prostate cancer at MRI, and gradient-weighted class activation maps localized the tumor.
DCD Liver Grafts Can Safely Be Used for Recipients With Grade I–II Portal Vein Thrombosis: A Multicenter Analysis

Transplantation Direct | October 7, 2022 | Volume: 8 | Issue: 11 | Pages: e1392

10.1097/txd.0000000000001392 | PMID 36246002

Background. With donation after circulatory death (DCD) liver transplantation (LT), the goal of the recipient implantation procedure is to minimize surgical complexity to avoid a tenuous environment for an already marginal graft. The presence of portal vein thrombosis (PVT) at the time of LT adds surgical complexity, yet‚ to date, no studies have investigated the utilization of DCD liver grafts for patients with PVT. Methods. All DCD LT performed at Mayo Clinic-Florida, Mayo Clinic-Arizona, and Mayo Clinic-Rochester from 2006 to 2020 were reviewed (N = 771). Patients with PVT at the time of transplant were graded using Yerdel classification. A 1:3 propensity match between patients with PVT and those without PVT was performed. Results. A total of 91 (11.8%) patients with PVT undergoing DCD LT were identified. Grade I PVT was present in 62.6% of patients, grade II PVT in 27.5%, grade III in 8.8%, and grade 4 in 1.1%. At the time of LT, thromboendovenectomy was performed in 89 cases (97.8%). There was no difference in the rates of early allograft dysfunction (43.2% versus 52.4%; P = 0.13) or primary nonfunction (1.1% versus 1.1%; P = 0.41) between the DCD PVT and DCD without PVT groups, respectively. The rate of ischemic cholangiopathy was not significantly different between the DCD PVT (11.0%) and DCD without PVT groups (10.6%; P = 0.92). Graft (P = 0.58) and patient survival (P = 0.08) were similar between the 2 groups. Graft survival at 1-, 3-, and 5-y was 89.9%, 84.5%, and 79.3% in the DCD PVT group. Conclusions. In appropriately selected recipients with grades I–II PVT, DCD liver grafts can be utilized safely with excellent outcomes.
Neural Transformers for Intraductal Papillary Mucosal Neoplasms (IPMN) Classification in MRI images

2022 44th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) | September 8, 2022 | Volume: No volume available | Issue: No issue available | Pages: 475-479

10.1109/embc48229.2022.9871547 | PMID 36085787

Editorial Comment: MRI Is Strengthening the Practice for Pancreatic Cancer Imaging

American Journal of Roentgenology | June 22, 2022 | Volume: 219 | Issue: 5 | Pages: 772-772

10.2214/ajr.22.28093 | PMID 35731104

Focal Nodular Hyperplasia and Focal Nodular Hyperplasia–like Lesions

RadioGraphics | June 10, 2022 | Volume: 42 | Issue: 4 | Pages: 1043-1061

10.1148/rg.210156 | PMID 35687520

Carcinosarcoma of the Ovary

No container title available | October 4, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1148/cases.20211939

Editorial Comment: Shift in Rectal Cancer Treatment Strategies

American Journal of Roentgenology | May 26, 2021 | Volume: 217 | Issue: 6 | Pages: 1294-1294

10.2214/ajr.21.26213 | PMID 34037414

Hepatic Mucinous Cystic Neoplasm Versus Simple Biliary Cyst: Assessment of Distinguishing Imaging Features Using CT and MRI

American Journal of Roentgenology | December 23, 2020 | Volume: 216 | Issue: 2 | Pages: 403-411

10.2214/ajr.20.22768 | PMID 33356432

Multimodality Imaging of Abdominopelvic Tumors with Venous Invasion

RadioGraphics | October 16, 2020 | Volume: 40 | Issue: 7 | Pages: 2098-2116

10.1148/rg.2020200047 | PMID 33064623

Krukenberg Tumors: Update on Imaging and Clinical Features

American Journal of Roentgenology | July 13, 2020 | Volume: 215 | Issue: 4 | Pages: 1020-1029

10.2214/ajr.19.22184 | PMID 32755184